NASDAQ$MRSN
Mersana Therapeutics Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Mersana reported financial results and business update for Q4 2022.
Mersana Therapeutics reported their Q4 and Full Year 2022 financial results, highlighting advancements in their lead product candidate UpRi, diversification of their clinical pipeline, new collaborations, and a strengthened financial position.
- Advanced UpRi in multiple clinical trials.
- Diversified clinical pipeline.
- Entered significant new collaborations.
- Strengthened financial position.
Headline financials
Revenue & EPS history
Mersana · Revenue · Quarterly
$14.7M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q4 2022
+1.4%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+1.3%
Avg return
30 days after
47%
17 / 36 earnings
Positive
+38.9%
Q2 2022
Best reaction
-20.3%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | +2.4% | +0.8% | +3.0% | |
| Q2 2025 | +11.6% | +22.3% | +18.6% | |
| Q1 2025 | -18.5% | -0.2% | -3.6% | |
| Q4 2024 | -8.3% | +3.6% | -36.7% | |
| Q3 2024 | +14.5% | -3.7% | -1.8% | |
| Q2 2024 | -13.4% | -7.2% | +25.2% | |
| Q1 2024 | -20.3% | -23.8% | -37.4% | |
| Q4 2023 | +27.4% | +33.8% | +4.8% | |
| Q3 2023 | -6.5% | -12.9% | +46.8% | |
| Q2 2023 | +0.0% | +4.2% | +6.7% | |
| Q1 2023 | +8.9% | +8.2% | +16.4% | |
| Q4 2022 | +7.0% | +4.4% | -26.3% | |
| Q3 2022 | -11.0% | — | — | |
| Q2 2022 | +38.9% | — | — | |
| Q1 2022 | -11.2% | — | — | |
| Q4 2021 | +14.4% | — | — | |
| Q3 2021 | -1.1% | — | — | |
| Q2 2021 | -2.1% | — | — | |
| Q1 2021 | -5.3% | — | — | |
| Q4 2020 | +7.7% | — | — | |
| Q3 2020 | -4.2% | — | — | |
| Q2 2020 | -1.9% | — | — | |
| Q1 2020 | -3.1% | — | — | |
| Q4 2019 | +3.5% | — | — | |
| Q3 2019 | +7.0% | — | — | |
| Q2 2019 | +2.3% | — | — | |
| Q1 2019 | +14.3% | — | — | |
| Q4 2018 | +4.0% | — | — | |
| Q3 2018 | +7.5% | — | — | |
| Q2 2018 | +0.0% | — | — | |
| Q1 2018 | -3.7% | — | — | |
| Q1 2016 | -8.9% | — | — | |
| Q3 2016 | -4.5% | — | — | |
| Q3 2017 | -5.1% | — | — | |
| Q4 2016 | +3.9% | — | — | |
| Q2 2016 | +3.9% | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro